SeqLL Inc. (SEQL)

OTCMKTS: SEQL · Delayed Price · USD
3.000
0.00 (0.00%)
Mar 26, 2024, 12:00 AM EDT - Market closed

Company Description

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide.

It focus on development of scientific assets and novel intellectual property across multiple omics fields.

The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data.

It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies.

In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease.

Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support.

The company was founded in 2013 and is headquartered in Billerica, Massachusetts.

SeqLL Inc.
SeqLL logo
Country MA
Founded 2014
IPO Date Aug 27, 2021
Industry Diagnostics & Research
Sector Healthcare
Employees 7

Contact Details

Address:
317 New Boston Street, Suite 210
Woburn, Massachusetts 01801
United States
Phone (781) 817-3755

Stock Details

Ticker Symbol SEQL
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.75
CIK Code 0001605888
Employer ID 46-5319744
SIC Code 7363

Key Executives

Name Position
Daniel Robert Jones Co-Founder, President, Chief Executive Officer and Chairman
Frances P. Scally Chief Financial Officer and Secretary
Erik Volke Director of Operations
Brian Paras Chief Business Officer

Latest SEC Filings

Date Type Title
Mar 25, 2024 8-K Current Report
Mar 21, 2024 25-NSE Filing
Feb 12, 2024 EFFECT Notice of Effectiveness
Feb 12, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 9, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 8, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 2, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 1, 2024 UPLOAD Filing
Jan 31, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jan 29, 2024 UPLOAD Filing